Fig. 2From: In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016–2018)Rates of resistant respiratory Pseudomonas aeruginosa isolates by subset/region (ATLAS 2016–2018). aAfrica/Middle East, 471; Asia/South Pacific, 1007; Europe, 3049; Latin America, 805. bIsolates in this subset are carbapenemase-positive and MBL-positiveBack to article page